Literature DB >> 22539353

A novel classification system to predict the pathogenic effects of CHD7 missense variants in CHARGE syndrome.

Jorieke E H Bergman1, Nicole Janssen, Almer M van der Sloot, Hermien E K de Walle, Jeroen Schoots, Nanna D Rendtorff, Lisbeth Tranebjaerg, Lies H Hoefsloot, Conny M A van Ravenswaaij-Arts, Robert M W Hofstra.   

Abstract

CHARGE syndrome is characterized by the variable occurrence of multisensory impairment, congenital anomalies, and developmental delay, and is caused by heterozygous mutations in the CHD7 gene. Correct interpretation of CHD7 variants is essential for genetic counseling. This is particularly difficult for missense variants because most variants in the CHD7 gene are private and a functional assay is not yet available. We have therefore developed a novel classification system to predict the pathogenic effects of CHD7 missense variants that can be used in a diagnostic setting. Our classification system combines the results from two computational algorithms (PolyPhen-2 and Align-GVGD) and the prediction of a newly developed structural model of the chromo- and helicase domains of CHD7 with segregation and phenotypic data. The combination of different variables will lead to a more confident prediction of pathogenicity than was previously possible. We have used our system to classify 145 CHD7 missense variants. Our data show that pathogenic missense mutations are mainly present in the middle of the CHD7 gene, whereas benign variants are mainly clustered in the 5' and 3' regions. Finally, we show that CHD7 missense mutations are, in general, associated with a milder phenotype than truncating mutations.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539353     DOI: 10.1002/humu.22106

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  29 in total

1.  Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria.

Authors:  Caitlin L Hale; Adrienne N Niederriter; Glenn E Green; Donna M Martin
Journal:  Am J Med Genet A       Date:  2015-11-21       Impact factor: 2.802

2.  Clinical utility gene card for: CHARGE syndrome - update 2015.

Authors:  Conny M A van Ravenswaaij-Arts; Kim Blake; Lies Hoefsloot; Alain Verloes
Journal:  Eur J Hum Genet       Date:  2015-02-18       Impact factor: 4.246

3.  A functional assay to study the pathogenicity of CHD7 protein variants encountered in CHARGE syndrome patients.

Authors:  Gara Samara Brajadenta; Frédéric Bilan; Brigitte Gilbert-Dussardier; Alain Kitzis; Vincent Thoreau
Journal:  Eur J Hum Genet       Date:  2019-07-09       Impact factor: 4.246

Review 4.  CHARGE syndrome: a review of the immunological aspects.

Authors:  Monica T Y Wong; Elisabeth H Schölvinck; Annechien J A Lambeck; Conny M A van Ravenswaaij-Arts
Journal:  Eur J Hum Genet       Date:  2015-02-18       Impact factor: 4.246

Review 5.  Cardiac Neural Crest Cells: Their Rhombomeric Specification, Migration, and Association with Heart and Great Vessel Anomalies.

Authors:  Olivier Schussler; Lara Gharibeh; Parmeseeven Mootoosamy; Nicolas Murith; Vannary Tien; Anne-Laure Rougemont; Tornike Sologashvili; Erik Suuronen; Yves Lecarpentier; Marc Ruel
Journal:  Cell Mol Neurobiol       Date:  2020-05-13       Impact factor: 5.046

6.  CHD7 gene polymorphisms and familial idiopathic scoliosis.

Authors:  Mera K Tilley; Cristina M Justice; Kandice Swindle; Beth Marosy; Alexander F Wilson; Nancy H Miller
Journal:  Spine (Phila Pa 1976)       Date:  2013-10-15       Impact factor: 3.468

7.  More Clinical Overlap between 22q11.2 Deletion Syndrome and CHARGE Syndrome than Often Anticipated.

Authors:  N Corsten-Janssen; S C Saitta; L H Hoefsloot; D M McDonald-McGinn; D A Driscoll; R Derks; K A Dickinson; W S Kerstjens-Frederikse; B S Emanuel; E H Zackai; C M A van Ravenswaaij-Arts
Journal:  Mol Syndromol       Date:  2013-05-28

8.  A gene-specific method for predicting hemophilia-causing point mutations.

Authors:  Nobuko Hamasaki-Katagiri; Raheleh Salari; Andrew Wu; Yini Qi; Tal Schiller; Amanda C Filiberto; Enrique F Schisterman; Anton A Komar; Teresa M Przytycka; Chava Kimchi-Sarfaty
Journal:  J Mol Biol       Date:  2013-08-03       Impact factor: 5.469

9.  Novel Frameshift CHD7 Mutation Related to CHARGE Syndrome.

Authors:  E Martínez-Quintana; F Rodríguez-González; P Garay-Sánchez; A Tugores
Journal:  Mol Syndromol       Date:  2013-10-04

10.  Using exome data to identify malignant hyperthermia susceptibility mutations.

Authors:  Stephen G Gonsalves; David Ng; Jennifer J Johnston; Jamie K Teer; Peter D Stenson; David N Cooper; James C Mullikin; Leslie G Biesecker
Journal:  Anesthesiology       Date:  2013-11       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.